Literature DB >> 6108172

Effects of histamine on monocyte complement production. I. Inhibition of C2 production mediated by its action on H2 receptors.

D Lappin, K Whaley.   

Abstract

Histamine produced dose-dependent inhibition of the production of the second complement component (C2) by monocytes in tissue culture. The effect was not associated with either cell death, as ascertained by trypan blue exclusion, or loss of cells from the monolayer, as determined by measuring their DNA content. The specificity of the response was shown by the failure of histidine or histamine metabolites to inhibit C2 production. Preincubation of histamine with histaminase also abrogated the histamine effect. The kinetics of the effect were extremely rapid and irreversible, most of the reduction being achieved during a 5-min exposure to histamine. The H2 receptor antagonist cimetidine was able to prevent the histamine response, whereas chlorpheniramine, the H1 receptor antagonist, had no effect. Dimaprit and 4-methyl histamine, H2 receptor agonists, simulated the effect of histamine whereas the H1 receptor agonist 2-(2-aminoethylthiazole) was ineffective, confirming that the effect of histamine on C2 production by monocytes is mediated by the H2 receptors. Thus histamine, released from basophils or mast cells by the C3 and C5 cleavage products C3a and C5a respectively, may exert a negative feedback on further C3 and C5 cleavage by limiting the formation of the C3 (C42) and C5 (C423b) convertases.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6108172      PMCID: PMC1537048     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  18 in total

1.  The role of cyclic 3',5' adenosine monophosphate in the specific cytolytic activity of lymphocytes.

Authors:  C S Henney; H R Bourne; L M Lichtenstein
Journal:  J Immunol       Date:  1972-06       Impact factor: 5.422

2.  A stoichiometric assay for the fourth component of complement in whole human serum using EAC'la-gp and functionally pure human second component.

Authors:  S Ruddy; K F Austen
Journal:  J Immunol       Date:  1967-12       Impact factor: 5.422

Review 3.  Modulation of inflammation and immunity by cyclic AMP.

Authors:  H R Bourne; L M Lichtenstein; K L Melmon; C S Henney; Y Weinstein; G M Shearer
Journal:  Science       Date:  1974-04-05       Impact factor: 47.728

4.  Inhibition of histamine release by histamine controlled by H2 receptor.

Authors:  L M Lichtenstein; E Gillespie
Journal:  Nature       Date:  1973-08-03       Impact factor: 49.962

5.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

6.  Increase in histamine receptors on thymus-derived effector lymphocytes during the primary immune response to alloantigens.

Authors:  M Plaut; L M Lichtenstein; C S Henney
Journal:  Nature       Date:  1973-08-03       Impact factor: 49.962

7.  Receptors for histamine can be detected on the surface of selected leukocytes.

Authors:  K L Melmon; H R Bourne; J Weinstein; M Sela
Journal:  Science       Date:  1972-08-25       Impact factor: 47.728

8.  Histamine augments leukocyte adenosine 3',5'-monophosphate and blocks antigenic histamine release.

Authors:  H R Bourne; K L Melmon; L M Lichtenstein
Journal:  Science       Date:  1971-08-20       Impact factor: 47.728

9.  Specific leukocyte receptors for small endogenous hormones. Detection by cell binding to insolubilized hormone preparations.

Authors:  Y Weinstein; K L Melmon; H R Bourne; M Sela
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

10.  Regulation of antibody response by cells expressing histamine receptors.

Authors:  G M Shearer; K L Melmon; Y Weinstein; M Sela
Journal:  J Exp Med       Date:  1972-11-01       Impact factor: 14.307

View more
  12 in total

1.  Adrenergic receptors on monocytes modulate complement component synthesis.

Authors:  D Lappin; K Whaley
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

Review 2.  Complement biosynthesis by mononuclear phagocytes.

Authors:  A R McPhaden; K Whaley
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 3.  Synthesis of complement by macrophages and modulation of their functions through complement activation.

Authors:  H P Hartung; U Hadding
Journal:  Springer Semin Immunopathol       Date:  1983

4.  Inhibition of lymphocyte proliferation by histamine and related compounds not mediated via H1- or H2- receptors.

Authors:  D Gordon; G P Lewis; A M Nouri
Journal:  Br J Pharmacol       Date:  1981-09       Impact factor: 8.739

5.  Cyclic nucleotides and their relationship to complement-component-C2 synthesis by human monocytes.

Authors:  D Lappin; D W Riches; B Damerau; K Whaley
Journal:  Biochem J       Date:  1984-09-01       Impact factor: 3.857

6.  Interleukin-6 biosynthesis is increased by histamine in human B-cell and glioblastoma cell lines.

Authors:  A Falus
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

7.  Serum-treated antigen-antibody complexes inhibit the production of C2 and factor B by mononuclear phagocytes.

Authors:  K Whaley; D Lappin; A O Hamilton
Journal:  Immunology       Date:  1983-02       Impact factor: 7.397

8.  Prostaglandins and prostaglandin synthetase inhibitors regulate the synthesis of complement components by human monocytes.

Authors:  D F Lappin; K Whaley
Journal:  Clin Exp Immunol       Date:  1982-09       Impact factor: 4.330

9.  Effect of histamine on monocyte complement production. II. Modulation of protein secretion, degradation and synthesis.

Authors:  D Lappin; H L Moseley; K Whaley
Journal:  Clin Exp Immunol       Date:  1980-12       Impact factor: 4.330

10.  Control of monocyte C2 production by cyclic AMP.

Authors:  D Lappin; K Whaley
Journal:  Immunology       Date:  1983-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.